Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Stem cell therapy for central nerve system injuries: glial cells hold the key.
Effects of intrathecal triamincinolone-acetonide treatment in MS patients with therapy-resistant spasticity.
Clinical predictors of disease progression in multiple sclerosis patients with relapsing onset in a nation-wide cohort.
Cognitive correlates of under-ambiguity and under-risk decision making in high-functioning patients with relapsing remitting multiple sclerosis.
Bi-exponential diffusion signal decay in normal appearing white matter of multiple sclerosis.
Walking speed, rather than Expanded Disability Status Scale, relates to long-term patient-reported impact in progressive MS.
Purkinje cell fusion and binucleate heterokaryon formation in multiple sclerosis cerebellum.
Depression screening in Black Americans with multiple sclerosis.
Characteristic cerebrospinal fluid cytokine/chemokine profiles in neuromyelitis optica, relapsing remitting or primary progressive multiple sclerosis.
Blocking LINGO-1 as a Therapy to Promote CNS Repair: From Concept to the Clinic.
Glia in mammalian development and disease.
Inflammation-independent defective early B cell tolerance checkpoints in rheumatoid arthritis.
Identity of the elusive IgM Fc receptor (FcmuR) in humans.
Hippocampal volume is related to cognitive decline and fornicial diffusion measures in multiple sclerosis.
Assessment and rehabilitation of driver skills: subjective experiences of people with multiple sclerosis and health professionals.
Structure-activity relationship study, target identification, and pharmacological characterization of a small molecular IL-12/23 inhibitor, APY0201.
Multiple sclerosis care in Latin America.
Management of pain in advanced disease.
Paroxysmal chorea as a relapse of myelopathy in a patient with neuromyelitis optica.
Efficacy and safety of natalizumab in multiple sclerosis: interim observational programme results.
Adverse socioeconomic position during the life course is associated with multiple sclerosis.
Resveratrol augments therapeutic efficiency of mouse bone marrow mesenchymal stem cell-based therapy in experimental autoimmune encephalomyelitis.
Efficacy and safety of FTY720 in patients with relapsing multiple sclerosis
Time-Domain and Spectral-Domain Optical Coherence Tomography of Retinal Nerve Fiber Layer in MS Patients and Healthy Controls.
Burden and quality of life in caregivers of persons with multiple sclerosis.
Pages
« first
‹ previous
…
289
290
291
292
293
294
295
296
297
…
next ›
last »